Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

96.94
+0.26000.27%
Post-market: 96.940.00000.00%19:30 EDT
Volume:9K
Turnover:882.27K
Market Cap:399.39M
PE:54.06
High:96.95
Open:96.84
Low:96.67
Close:96.68
52wk High:98.82
52wk Low:67.69
Shares:4.12M
Float Shares:4.12M
Volume Ratio:0.47
T/O Rate:0.22%
Dividend:1.55
Dividend Rate:1.60%
EPS(TTM):1.79
EPS(LYR):18.65
ROE:24.76%
ROA:0.08%
PB:1.61
PE(LYR):5.20

Loading ...

Immuneering Expects Cash Runway to Fund Operations into 2029

Reuters
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Exagen (XGN), Amgen (AMGN) and Arvinas Holding Company (ARVN)

TIPRANKS
·
Aug 05

Royalty Pharma Q2 Adj. EPS $1.32 Beats $1.28 Estimate, Sales $674.000M Miss $693.190M Estimate

Benzinga Earnings
·
Aug 05

Royalty Pharma Q2 Net Income Falls, Revenue Rises

MT Newswires Live
·
Aug 05

Royalty Pharma Q2 GAAP Net Income Attributable to Company Falls 44% to $18 Million; Non-GAAP Adjusted Ebitda Rises 16% to $736 Million

Reuters
·
Aug 05

Royalty Pharma Q2 Adjusted Ebitda Beats Estimates

Reuters
·
Aug 05

Royalty Pharma Reports Second Quarter 2026 Results

THOMSON REUTERS
·
Aug 05

Royalty Pharma: Outlook 2026 Portfolio Receipts $3,400 Mln to $3,500 Mln, Interest Paid $350 Mln to $360 Mln

THOMSON REUTERS
·
Aug 05

Amgen Inc : Scotiabank Raises Target Price to $450 from $385

THOMSON REUTERS
·
Aug 05

Sino Biopharmaceutical Stock Slips 1.2% in Hong Kong

Dow Jones
·
Aug 05

Street View: Amgen Builds Momentum with Blockbusters, Biosimilars and a Pipeline in Waiting

Reuters
·
Aug 05

Amgen Inc : Morgan Stanley Raises Target Price to $351 from $333

THOMSON REUTERS
·
Aug 05

Amgen Inc : Oppenheimer Raises Target Price to $450 from $400

THOMSON REUTERS
·
Aug 05

Dow Jones Top Company Headlines at 7 PM ET: SpaceX Revenue Could Reach $1 Trillion, Elon Musk Says | Paramount's ...

Dow Jones
·
Aug 05

Amgen Announces Availability of Q2 2026 Earnings Report Release

Reuters
·
Aug 05

Amgen's Strong Second Quarter Drug Sales Drive Upward Forecast Revision and Early-Stage Weight Loss Drug Termination

Deep News
·
Aug 05

Amgen Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 05

Amgen Exec Says Continues to Expect Capital Expenditures of About $2.6 Billion in 2026 to Scale Manufacturing Capacity, Including for Maritide's Launch

THOMSON REUTERS
·
Aug 05

Amgen Exec Says Expect a Meaningful Sequential Increase in Operating Expenses in the Third Quarter

THOMSON REUTERS
·
Aug 05